Enliven Therapeutics (ELVN) shares are in focus after the company reported encouraging initial Phase 1b data for ELVN-001 in heavily pretreated chronic myeloid leukemia patients, with efficacy and ...
Humans have always been fascinated with space. We frequently question whether we are alone in the universe. If not, what does ...